This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Bayer Intellectual Property Gmbh. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: Klaus Weidemann: Innovator in Pharmaceutical Chemistry
Introduction
Klaus Weidemann is a notable inventor based in Wuppertal, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of processes for synthesizing important compounds.
Latest Patents
One of his key inventions is a patent titled "Process for preparing pradofloxacin." This invention relates to an improved method for synthesizing pradofloxacin, where the substituent in the 7 position is introduced through nucleophilic substitution in a solvent mixture of N-methylpyrrolidone and ethanol. Klaus Weidemann holds 1 patent in this area.
Career Highlights
Throughout his career, Klaus has worked with prominent companies in the pharmaceutical industry. He has been associated with Bayer Intellectual Property GmbH and Bayer Animal Health GmbH, where he contributed to various innovative projects.
Collaborations
Klaus has collaborated with several professionals in his field, including Ralf Wischnat and Thomas Adam. Their combined expertise has furthered advancements in pharmaceutical processes.
Conclusion
Klaus Weidemann's work in the field of pharmaceutical chemistry, particularly his patent for the preparation of pradofloxacin, showcases his innovative spirit and dedication to advancing medical science. His contributions continue to impact the industry positively.